Targeting cancer cell metabolism-designing new cancer therapies

The metabolism of cancer cells differs from that of healthy cells. Which therapeutic options does this hold and what innovations might be driven by research?

At the Metabolism-based Cancer Therapy Symposium on 08.10.2021, scientists and oncologists from around the world reported on their research and discussed future therapy options. Prof. Matthew van der Heiden, director of the Koch Institute for Integrative Cancer Research at MIT, (Harvard) gave a broad overview in his presentation How understanding cancer metabolism informs therapy. At the following Future directions panel discussion, the leading organizers Dr. Mohamed Elgendy and Ekaterina Balaian, MD, discussed the emerging findings. 

The hybrid symposium, organized by the Mildred Scheel Early Career Center Dresden, countedt more than 150 participants. In addition to the cutting-edge presentations by the renowned speakers from Milan, Frankfurt, Canada and the USA, the audience enjoyed a graphical recording of the keynote lecture and the panel discussion. This graphical summary was created by Dr. Franziska Schwarz (SciVisTo) during the presentations. The panel discussion poster summarizes the burning questions in this field of research and shows that, for example, reducing caloric intake has the potential of cancer prevention or cancer therapy. It is now important to verify the basic scientific results in clinical studies in the future. 

If you want to get more information about the lectures or if you want to have a look at all graphical recordings, please visit the MSNZ Events Webpage.